Provided by Tiger Fintech (Singapore) Pte. Ltd.

Alector Inc.

0.9734
+0.05335.79%
Volume:673.02K
Turnover:644.46K
Market Cap:96.45M
PE:-0.79
High:0.9900
Open:0.9201
Low:0.9040
Close:0.9201
Loading ...

Company Profile

Company Name:
Alector Inc.
Exchange:
NASDAQ
Establishment Date:
2013
Employees:
238
Office Location:
131 Oyster Point Boulevard,Suite 600,South San Francisco,California,United States
Zip Code:
94080
Fax:
- -
Introduction:
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, an immune activity in the brain with genetic links to multiple neurodegenerative disorders, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis diseases; and AL101 that is in Phase I clinical trial for the treatment of neurodegenerative diseases, including Alzheimer's and Parkinson's diseases. The company also offers AL002, a product candidate that is in Phase II clinical trial for the treatment of Alzheimer's disease; and AL003, which is in Phase I clinical trial for the treatment of Alzheimer's disease. Its pipeline products include AL044 that targets MS4A4A, a risk gene for Alzheimer's disease. Alector, Inc. has a collaboration agreement with Adimab, LLC for the research and development of antibodies; and a strategic collaboration agreement with GlaxoSmithKline plc for the development and commercialization of monoclonal antibodies, such as AL001, AL002, and AL101 to treat neurodegenerative diseases. Alector, Inc. was founded in 2013 and is headquartered in South San Francisco, California.

Directors

Name
Position
Arnon Rosenthal
Co-founder, Chief Executive Officer and Director
Tillman Gerngross
Chairman and Director
David Wehner
Independent Director
Kristine Yaffe
Independent Director
Louis J. Lavigne, Jr.
Independent Director
Paula Hammond
Independent Director
Terry McGuire
Independent Director
Richard Scheller
Director

Shareholders

Name
Position
Arnon Rosenthal
Co-founder, Chief Executive Officer and Director
Shehnaaz Suliman
President and Chief Operating Officer
Calvin Yu
Vice President, Finance
Robert King
Chief Development Officer
Robert Paul
Chief Medical Officer
Sabah Oney
Chief Business Officer